Abstract
Purpose
The study aimed to describe the dispensing of benzodiazepines and benzodiazepine-related drugs (z-hypnotics) to pregnant women and to study the characteristics of these women and the extent of co-medication.
Methods
A population-based cohort study was conducted based on the linkage of nationwide registries: the Medical Birth Registry of Norway and the Norwegian Prescription Database. The data covers dispensed drugs to women 3 months prior to, during and after pregnancy. The study population consisted of 345,703 singleton pregnancies during a period starting 1 April 2004 or later and ending before 1 January 2011.
Results
In 5,135 (1.5 %) of the pregnancies, the women were dispensed a benzodiazepine or z-hypnotic at least once. Of these, 68.5 % filled just one prescription for the duration of the pregnancy. Prevalence was lower in pregnancy than before and after pregnancy. The median total amount of benzodiazepines and/or z-hypnotics dispensed during pregnancy was 15 defined daily doses (DDDs), while the 25 % receiving the largest amounts got 40 DDDs or more. Five hundred eleven women, the 10 % that were prescribed the largest amounts during pregnancy, received a median amount of 220 DDDs. Women receiving these drugs were older, more often smokers, without a partner and suffering from chronic disease. Of the medicated pregnant women, 19.6 % and 19.3 % were also prescribed an opioid and antidepressant, respectively.
Conclusions
The use of benzodiazepines and z-hypnotic drugs during pregnancy was not very prevalent in Norway. However, our findings imply that there is a substantial number of pregnancies where these drugs are dispensed often and/or in large quantities and where co-medication occurred.
Similar content being viewed by others
References
Sahota PK, Jain SS, Dhand R (2003) Sleep disorders in pregnancy. Curr opin pulm med 9(6):477–483
Rubertsson C, Hellstrom J, Cross M, Sydsjo G (2014) Anxiety in early pregnancy: prevalence and contributing factors. Arch wom mental health. doi:10.1007/s00737-013-0409-0
EMA (2008) Guideline on risk assessment of medicinal products on human reproduction and lactation: from data to labelling. European Medicines Agency. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003307.pdf. Accessed 17 July 2014.
Wikner BN, Stiller CO, Bergman U, Asker C, Kallen B (2007) Use of benzodiazepines and benzodiazepine receptor agonists during pregnancy: neonatal outcome and congenital malformations. Pharmacoepidemiol Drug Saf 16(11):1203–1210. doi:10.1002/pds.1457
Fass (2013) Fakta för förskrivare (Facts for prescribers). Läkemedelsindustriföreningens Service AB. http://www.fass.se/LIF/healthcarefacts;jsessionid=e6bU63h_JvcfYv86OU0S8hJE6Nihi6MGJVamYV2RNIqtaeZaTNrb!1437283995?docId=18338&userType=0. Accessed 13 August 2014.
Bennett PN, Working Group WHO (eds) (1988) Drugs and human lactation. Elsevier, Amsterdam, New York, Oxford
Tamanna S, Geraci SA (2013) Major sleep disorders among women: (women's health series). South Med J 106(8):470–478. doi:10.1097/SMJ.0b013e3182a15af5
Garbis H, McElhatton PR (2007) 2.11 - Psychotropic drugs. In: Schaefer C, Peters P, Miller RK (Eds.) Drugs During Pregnancy and Lactation (Second Edition)ed. Academic , pp288-320
Engeland A, Bramness JG, Daltveit AK, Ronning M, Skurtveit S, Furu K (2008) Prescription drug use among fathers and mothers before and during pregnancy. A population-based cohort study of 106,000 pregnancies in Norway 2004–2006. Br J Clin Pharmacol 65(5):653–660. doi:10.1111/j.1365-2125.2008.03102.x
Lacroix I, Hurault C, Sarramon MF, Guitard C, Berrebi A, Grau M, Albouy-Cossard C, Bourrel R, Elefant E, Montastruc JL, Damase-Michel C (2009) Prescription of drugs during pregnancy: a study using EFEMERIS, the new French database. Eur J Clin Pharmacol 65(8):839–846. doi:10.1007/s00228-009-0647-2
Andrade SE, Gurwitz JH, Davis RL, Chan KA, Finkelstein JA, Fortman K, McPhillips H, Raebel MA, Roblin D, Smith DH, Yood MU, Morse AN, Platt R (2004) Prescription drug use in pregnancy. Am J Obstet Gynecol 191(2):398–407. doi:10.1016/j.ajog.2004.04.025
Daw JR, Mintzes B, Law MR, Hanley GE, Morgan SG (2012) Prescription drug use in pregnancy: a retrospective, population-based study in British Columbia, Canada (2001–2006). ClinTher 34(1):239–249. doi:10.1016/j.clinthera
Lupattelli A, Spigset O, Twigg MJ, Zagorodnikova K, Mardby AC, Moretti ME, Drozd M, Panchaud A, Hameen-Anttila K, Rieutord A, Gjergja Juraski R, Odalovic M, Kennedy D, Rudolf G, Juch H, Passier A, Bjornsdottir I, Nordeng H (2014) Medication use in pregnancy: a cross-sectional, multinational web-based study. BMJ open 4(2):e004365. doi:10.1136/bmjopen-2013-004365
NorPD (2014) Statistics from the Norwegian Prescription Database. Norwegian Prescription Database. http://www.reseptregisteret.no/. Accessed 13 August 2014.
Neutel CI, Skurtveit S, Berg C, Sakshaug S (2013) Multiple prescribers in older frequent opioid users—does it mean abuse? Journal of population therapeutics and clinical pharmacology = Journal de la therapeutique des populations et de la pharamcologie clinique 20 (3): e397-405
Mellbye A, Svendsen K, Borchgrevink PC, Skurtveit S, Fredheim OM (2012) Concomitant medication among persistent opioid users with chronic non-malignant pain. Acta Anaesthesiol Scand 56(10):1267–1276. doi:10.1111/j.1399-6576.2012.02766.x
Handal M, Engeland A, Ronning M, Skurtveit S, Furu K (2011) Use of prescribed opioid analgesics and co-medication with benzodiazepines in women before, during, and after pregnancy: a population-based cohort study. Eur J Clin Pharmacol 67(9):953–960. doi:10.1007/s00228-011-1030-7
Hausken AM, Furu K, Tverdal A, Skurtveit S (2010) Mental distress and subsequent use of anxiolytic drugs—a prospective population-based cohort study of 16,000 individuals. Scandinavian J Public Health 38(5):465–473. doi:10.1177/1403494810370229
Furu K, Wettermark B, Andersen M, Martikainen JE, Almarsdottir AB, Sorensen HT (2010) The Nordic countries as a cohort for pharmacoepidemiological research. Basic Clin Pharmacol Toxicol 106(2):86–94. doi:10.1111/j.1742-7843.2009.00494.x
WHO Collaborating Centre for Drug Statistics Methodology (2011) ATC classification index with DDDs 2012. Organization, World Health
Irgens LM (2002) Medical birth registry—an essential resource in perinatal medical research. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 122(26):2546–2549
Irgens LM (2000) The Medical Birth Registry of Norway. Epidemiological research and surveillance throughout 30 years. Acta Obstet Gynecol Scand 79(6):435–439
Skurtveit S, Selmer R, Roth C, Hernandez-Diaz S, Handal M (2014) Prenatal exposure to antidepressants and language competence at age three: results from a large population-based pregnancy cohort in Norway. BJOG Int J Obstet Gynaecol. doi:10.1111/1471-0528.12821
Marchetti F, Romero M, Bonati M, Tognoni G (1993) Use of psychotropic drugs during pregnancy. A report of the international co-operative drug use in pregnancy (DUP) study. Collaborative Group on Drug Use in Pregnancy (CGDUP). Eur J Clin Pharmacol 45(6):495–501
Kulaga S, Zargarzadeh AH, Berard A (2009) Prescriptions filled during pregnancy for drugs with the potential of fetal harm. BJOG: an International Journal of Obstetrics and Gynaecology 116(13):1788–1795. doi:10.111/j.1471-0528.2009.02377.x
Skurtveit S, Selmer R, Odsbu I, Handal M (2014) Self-reported data on medicine use in the Norwegian Mother and Child cohort study compared to data from the Norwegian Prescription Database. Submitted
NDH (2013) Nasjonal faglig veileder vanedannende legemidler-rekvirering og forsvarlighet: graviditet. The Norwegian Directorate of Health. http://helsedirektoratet.no/sites/vanedannende-legemidler/utfordrende-situasjoner-og-tilstander/graviditet/Sider/default.aspx. Accessed 14 August 2014.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
ESM 1
(XLS 46 kb)
Rights and permissions
About this article
Cite this article
Riska, B.S., Skurtveit, S., Furu, K. et al. Dispensing of benzodiazepines and benzodiazepine-related drugs to pregnant women: a population-based cohort study. Eur J Clin Pharmacol 70, 1367–1374 (2014). https://doi.org/10.1007/s00228-014-1744-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-014-1744-4